{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T19:36:33Z","timestamp":1790019393688,"version":"4.0.1"},"reference-count":42,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,17]],"date-time":"2024-07-17T00:00:00Z","timestamp":1721174400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy - Nucleic Acids"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.omtn.2024.102282","type":"journal-article","created":{"date-parts":[[2024,7,19]],"date-time":"2024-07-19T21:27:53Z","timestamp":1721424473000},"page":"102282","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Suppression of HSV-1 infection and viral reactivation by CRISPR-Cas9 gene editing in 2D and 3D culture models"],"prefix":"10.1016","volume":"35","author":[{"given":"Anna","family":"Bellizzi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Senem","family":"\u00c7ak\u0131r","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Donadoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahsan","family":"Sariyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuren","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guo-Xiang","family":"Ruan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Gordon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamel","family":"Khalili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0641-6141","authenticated-orcid":false,"given":"Ilker K.","family":"Sariyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.omtn.2024.102282_bib1","series-title":"Herpes Simplex Virus Methods in Molecular Biology","first-page":"1","article-title":"Tour de Herpes: Cycling Through the Life and Biology of HSV-1","author":"Denes","year":"2020"},{"key":"10.1016\/j.omtn.2024.102282_bib3","doi-asserted-by":"crossref","first-page":"4797","DOI":"10.1128\/jvi.68.8.4797-4810.1994","article-title":"The herpes simplex virus regulatory protein ICP27 contributes to the decrease in cellular mRNA levels during infection","volume":"68","author":"Hardwicke","year":"1994","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.omtn.2024.102282_bib4","doi-asserted-by":"crossref","first-page":"7709","DOI":"10.1128\/JVI.72.10.7709-7714.1998","article-title":"The Role of Herpes Simplex Virus ICP27 in the Regulation of UL24 Gene Expression by Differential Polyadenylation","volume":"72","author":"Hann","year":"1998","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.omtn.2024.102282_bib5","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1006\/viro.2001.0902","article-title":"Herpes Simplex Virus 1 ICP27 Is Required for Transcription of Two Viral Late (\u03b32) Genes in Infected Cells","volume":"283","author":"Jean","year":"2001","journal-title":"Virology"},{"key":"10.1016\/j.omtn.2024.102282_bib6","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1128\/jvi.64.4.1704-1715.1990","article-title":"Genetic evidence for two distinct transactivation functions of the herpes simplex virus alpha protein ICP27","volume":"64","author":"Rice","year":"1990","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.omtn.2024.102282_bib7","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1128\/jvi.70.3.1969-1980.1996","article-title":"Herpes simplex ICP27 mutant viruses exhibit reduced expression of specific DNA replication genes","volume":"70","author":"Uprichard","year":"1996","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.omtn.2024.102282_bib8","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.2217\/fmb.11.119","article-title":"The many roles of the highly interactive HSV protein ICP27, a key regulator of infection","volume":"6","author":"Sandri-Goldin","year":"2011","journal-title":"Future Microbiol."},{"key":"10.1016\/j.omtn.2024.102282_bib9","doi-asserted-by":"crossref","first-page":"5910","DOI":"10.1128\/JVI.00267-11","article-title":"A pre-immediate-early role for tegument ICP0 in the proteasome-dependent entry of herpes simplex virus","volume":"85","author":"Delboy","year":"2011","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.omtn.2024.102282_bib10","series-title":"Alpha Herpesviruses. Molecular and Cellular Biology","first-page":"39","article-title":"The roles of ICP0 during HSV-1 infection","author":"Everett","year":"2006"},{"key":"10.1016\/j.omtn.2024.102282_bib11","series-title":"Alphaherpesviruses: Molecular Virology","first-page":"51","article-title":"The role of ICP0 in counteracting intrinsic cellular resistance to\u00a0virus infection","author":"Everett","year":"2011"},{"key":"10.1016\/j.omtn.2024.102282_bib12","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1099\/vir.0.048900-0","article-title":"Regulation of alphaherpesvirus infections by the ICP0 family of proteins","volume":"94","author":"Boutell","year":"2013","journal-title":"J.\u00a0Gen. Virol."},{"key":"10.1016\/j.omtn.2024.102282_bib13","doi-asserted-by":"crossref","first-page":"e00111-19","DOI":"10.1128\/JVI.00111-19","article-title":"Modeling Herpes Simplex Virus 1 Infections in Human Central Nervous System Neuronal Cells Using Two- and Three-Dimensional Cultures Derived from Induced Pluripotent Stem Cells","volume":"93","author":"D\u2019Aiuto","year":"2019","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.omtn.2024.102282_bib14","first-page":"4118","article-title":"Acyclovir in the Treatment of Herpes Viruses\u00a0\u2013 A Review","volume":"27","author":"K\u0142ysik","year":"2020","journal-title":"Comput. Mater. Continua (CMC)"},{"key":"10.1016\/j.omtn.2024.102282_bib15","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.virusres.2017.03.010","article-title":"CRISPR-Cas9 system-driven site-specific selection pressure on Herpes simplex virus genomes","volume":"244","author":"Li","year":"2018","journal-title":"Virus Res."},{"key":"10.1016\/j.omtn.2024.102282_bib16","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.omtm.2020.05.011","article-title":"Single AAV-Mediated CRISPR-SaCas9 Inhibits HSV-1 Replication by Editing ICP4 in Trigeminal Ganglion Neurons","volume":"18","author":"Chen","year":"2020","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.omtn.2024.102282_bib17","doi-asserted-by":"crossref","first-page":"814","DOI":"10.3390\/pathogens12060814","article-title":"CLEAR Strategy Inhibited HSV Proliferation Using Viral Vectors\u00a0Delivered CRISPR-Cas9","volume":"12","author":"Ying","year":"2023","journal-title":"Pathogens"},{"key":"10.1016\/j.omtn.2024.102282_bib18","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1134\/S0026893319010059","article-title":"A Plasmid-Expressed CRISPR\/Cas9 System Suppresses Replication of HSV Type I in a Vero Cell Culture","volume":"53","author":"Karpov","year":"2019","journal-title":"Mol. Biol."},{"key":"10.1016\/j.omtn.2024.102282_bib19","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1005701","article-title":"CRISPR\/Cas9-Mediated Genome Editing of Herpesviruses Limits Productive and Latent Infections","volume":"12","author":"van Diemen","year":"2016","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.omtn.2024.102282_bib20","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.51662","article-title":"Herpesviral lytic gene functions render the viral genome susceptible to novel editing by CRISPR\/Cas9","volume":"8","author":"Oh","year":"2019","journal-title":"Elife"},{"key":"10.1016\/j.omtn.2024.102282_bib21","article-title":"Complete and Prolonged Inhibition of Herpes Simplex Virus Type 1 Infection In\u00a0Vitro by CRISPR\/Cas9 and CRISPR\/CasX Systems","volume":"23","author":"Karpov","year":"2022","journal-title":"Int. J. Math. Stat."},{"key":"10.1016\/j.omtn.2024.102282_bib22","doi-asserted-by":"crossref","DOI":"10.1038\/srep23146","article-title":"Inhibition of HSV-1 Replication by Gene Editing Strategy","volume":"6","author":"Roehm","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.omtn.2024.102282_bib23","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1038\/nbt.3026","article-title":"Rational design of highly active sgRNAs for CRISPR-Cas9\u2013mediated gene inactivation","volume":"32","author":"Doench","year":"2014","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.omtn.2024.102282_bib24","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1038\/nbt.2647","article-title":"DNA targeting specificity of RNA-guided Cas9 nucleases","volume":"31","author":"Hsu","year":"2013","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.omtn.2024.102282_bib25","series-title":"Herpes Simplex Virus: Methods and Protocols","year":"2020"},{"key":"10.1016\/j.omtn.2024.102282_bib26","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.3390\/molecules24071349","article-title":"CRISPR\/Cas9-Based Antiviral Strategy: Current Status and the Potential Challenge","volume":"24","author":"Lee","year":"2019","journal-title":"Molecules"},{"key":"10.1016\/j.omtn.2024.102282_bib27","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.nbd.2004.03.005","article-title":"Adeno-associated virus 2-mediated gene therapy decreases autofluorescent storage material and increases brain mass in a murine model of infantile neuronal ceroid lipofuscinosis","volume":"16","author":"Griffey","year":"2004","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.omtn.2024.102282_bib28","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.ymthe.2005.11.008","article-title":"CNS-directed AAV2-mediated gene therapy ameliorates functional deficits in a murine model of infantile neuronal ceroid lipofuscinosis","volume":"13","author":"Griffey","year":"2006","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtn.2024.102282_bib29","doi-asserted-by":"crossref","first-page":"785","DOI":"10.3390\/cells12050785","article-title":"Various AAV Serotypes and Their Applications in Gene Therapy: An Overview","volume":"12","author":"Issa","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.omtn.2024.102282_bib30","series-title":"Progress in Nucleic Acid Research and Molecular Biology","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0079-6603(08)60878-8","article-title":"Transcription of the Herpes Simplex Virus Genome during Productive and Latent Infection","author":"Wagner","year":"1995"},{"key":"10.1016\/j.omtn.2024.102282_bib31","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jviromet.2014.11.009","article-title":"Engineering herpes simplex viruses by infection\u2013transfection methods including recombination site targeting by CRISPR\/Cas9 nucleases","volume":"213","author":"Russell","year":"2015","journal-title":"J.\u00a0Virol. Methods"},{"key":"10.1016\/j.omtn.2024.102282_bib32","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1111\/1348-0421.12180","article-title":"Engineering large viral DNA genomes using the CRISPR-Cas9 system","volume":"58","author":"Suenaga","year":"2014","journal-title":"Microbiol. Immunol."},{"key":"10.1016\/j.omtn.2024.102282_bib33","doi-asserted-by":"crossref","first-page":"6482","DOI":"10.1093\/nar\/gkw524","article-title":"Probing the impact of chromatin conformation on genome editing tools","volume":"44","author":"Chen","year":"2016","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.omtn.2024.102282_bib34","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.12677","article-title":"Nucleosomes impede Cas9 access to DNA in\u00a0vivo and in\u00a0vitro","volume":"5","author":"Horlbeck","year":"2016","journal-title":"Elife"},{"key":"10.1016\/j.omtn.2024.102282_bib35","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/nrmicro1794","article-title":"Chromatin control of herpes simplex virus lytic and latent infection","volume":"6","author":"Knipe","year":"2008","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.omtn.2024.102282_bib36","doi-asserted-by":"crossref","first-page":"4148","DOI":"10.1038\/s41467-020-17936-5","article-title":"Gene editing and elimination of latent herpes simplex virus in\u00a0vivo","volume":"11","author":"Aubert","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omtn.2024.102282_bib37","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1038\/s41587-020-00781-8","article-title":"Targeting herpes simplex virus with CRISPR\u2013Cas9 cures herpetic stromal keratitis in mice","volume":"39","author":"Yin","year":"2021","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.omtn.2024.102282_bib38","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s13365-023-01133-3","article-title":"iPSC-derived three-dimensional brain organoid models and neurotropic viral infections","volume":"29","author":"Swingler","year":"2023","journal-title":"J.\u00a0Neurovirol."},{"key":"10.1016\/j.omtn.2024.102282_bib39","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1038\/nature14299","article-title":"In\u00a0vivo genome editing using Staphylococcus aureus Cas9","volume":"520","author":"Ran","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.omtn.2024.102282_bib40","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1038\/nprot.2013.143","article-title":"Genome engineering using the CRISPR-Cas9 system","volume":"8","author":"Ran","year":"2013","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.omtn.2024.102282_bib41","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.virol.2017.09.016","article-title":"Shared ancestry of herpes simplex virus 1 strain Patton with recent clinical isolates from Asia and with strain KOS63","volume":"512","author":"Pourchet","year":"2017","journal-title":"Virology"},{"key":"10.1016\/j.omtn.2024.102282_bib42","doi-asserted-by":"crossref","first-page":"9192","DOI":"10.1128\/JVI.77.17.9192-9203.2003","article-title":"Association of the Herpes Simplex Virus Type 1\u00a0Us11 Gene Product with the Cellular Kinesin Light-Chain-Related Protein PAT1 Results in the Redistribution of Both Polypeptides","volume":"77","author":"Benboudjema","year":"2003","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.omtn.2024.102282_bib43","doi-asserted-by":"crossref","DOI":"10.1038\/mtna.2013.75","article-title":"In\u00a0vitro Inactivation of Latent HSV by Targeted Mutagenesis Using an HSV-specific Homing Endonuclease","volume":"3","author":"Aubert","year":"2014","journal-title":"Mol. Ther. Nucleic Acids"}],"container-title":["Molecular Therapy - Nucleic Acids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2162253124001690?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2162253124001690?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,10]],"date-time":"2024-10-10T02:34:54Z","timestamp":1728527694000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2162253124001690"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":42,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["S2162253124001690"],"URL":"https:\/\/doi.org\/10.1016\/j.omtn.2024.102282","relation":{},"ISSN":["2162-2531"],"issn-type":[{"value":"2162-2531","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Suppression of HSV-1 infection and viral reactivation by CRISPR-Cas9 gene editing in 2D and 3D culture models","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy - Nucleic Acids","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omtn.2024.102282","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Inc. on behalf of The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}],"article-number":"102282"}}